Bethesda North Marriott Hotel & Conference Center
5701 Marinelli Road
Bethesda, Maryland 20852

Overview
The Observational Medical Outcomes Partnership (OMOP) initial two-year program of work was designed to develop, implement, and empirically test the performance of a number of methods in identifying drug outcomes across multiple observational data sources. The research results provided empiric evidence to inform the implementation of any systematic surveillance system regarding the methods, data, and infrastructure necessary to identify and track emerging safety issues. Study results and lessons learned were shared in accordance with the public health mission of the Partnership.

Goals
Stakeholders gather at the OMOP 2012 Symposium to discuss key OMOP results, tools, and lessons learned. During the OMOP Symposium, the follow topics were discussed:

• Hear about study results regarding the performance of the methods implemented across the databases in the research lab and the distributed network.
• Explore the utility of OMOP-created tools for data characterization, quality assurance, and outcome definitions to support standardized processes within an active surveillance system.
• Review lessons learned along the initial OMOP 2-year journey.
• Learn about applications of the OMOP research beyond active surveillance.
• Meet with stakeholders and leaders in pharmacovigilance to understand their perspectives on drug safety systems and the impact of the OMOP Research.